Catalog No.
RVV02817
Species reactivity
Human respiratory syncytial virus A (strain A2)
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Applications
Blocking, ELISA, SPR
Target
Fusion glycoprotein F0, Fusion glycoprotein F2, F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1, F1, F, post-fusion
Concentration
1.66 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03420
Form
Liquid
Storage buffer
100 mM Pro-Ac, 20 mM Arg, pH 5.0
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
4D7
Note
For research use only.
Evaluate of the protective effect of an RSV Pre-F/Alum +CpG subunit vaccine in Balb/C mice with and without RSV prexposure. [RVV02817]
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization., PMID:2251875
Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage., PMID:1375280
Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic., PMID:11277694
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection., PMID:29029312
Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response., PMID:33574352
Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice. [RVV02817]
For research use only. Not for human or drug use.
